Alexza Pharma (ALXA) Tops Q4 EPS by 33c

Alexza Pharma (NASDAQ: ALXA) reported Q4 EPS of ($0.35), $0.33 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.45 billion, versus $1.3 million reported last year.

For earnings history and earnings-related data on Alexza Pharma (ALXA) click here.

You May Also Be Interested In

• Humana (HUM) surges on Q1 beat, reiterated adjusted earnings outlook
• AT&T (T) beats earnings estimates in Q1 but revenue falls short, shares climb
• Silicon Labs (SLAB) Tops Q1 EPS by 6c, Beats on Revenue; Offers Q2 Revenue Guidance